BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12503076)

  • 21. Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage.
    Paranjpe A; Zhang R; Ali-Osman F; Bobustuc GC; Srivenugopal KS
    Carcinogenesis; 2014 Mar; 35(3):692-702. PubMed ID: 24193513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.
    Zhang Z; Tang H; Wang Z; Zhang B; Liu W; Lu H; Xiao L; Liu X; Wang R; Li X; Wu M; Li G
    Mol Cancer; 2011 Sep; 10():124. PubMed ID: 21962230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.
    Leng S; Bernauer AM; Hong C; Do KC; Yingling CM; Flores KG; Tessema M; Tellez CS; Willink RP; Burki EA; Picchi MA; Stidley CA; Prados MD; Costello JF; Gilliland FD; Crowell RE; Belinsky SA
    Clin Cancer Res; 2011 Apr; 17(7):2014-23. PubMed ID: 21355081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction.
    Brell M; Ibáñez J; Tortosa A
    BMC Cancer; 2011 Jan; 11():35. PubMed ID: 21269507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus.
    Kuester D; El-Rifai W; Peng D; Ruemmele P; Kroeckel I; Peters B; Moskaluk CA; Stolte M; Mönkemüller K; Meyer F; Schulz HU; Hartmann A; Roessner A; Schneider-Stock R
    Cancer Lett; 2009 Mar; 275(1):117-26. PubMed ID: 19027227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.
    Hiraga J; Kinoshita T; Ohno T; Mori N; Ohashi H; Fukami S; Noda A; Ichikawa A; Naoe T
    Int J Hematol; 2006 Oct; 84(3):248-55. PubMed ID: 17050200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma.
    Ohno T; Hiraga J; Ohashi H; Sugisaki C; Li E; Asano H; Ito T; Nagai H; Yamashita Y; Mori N; Kinoshita T; Naoe T
    Int J Hematol; 2006 May; 83(4):341-7. PubMed ID: 16757436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas.
    Nakasu S; Fukami T; Baba K; Matsuda M
    J Neurooncol; 2004 Dec; 70(3):333-40. PubMed ID: 15662974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer.
    Esteller M; Herman JG
    Oncogene; 2004 Jan; 23(1):1-8. PubMed ID: 14712205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MGMT hypermethylation: a prognostic foe, a predictive friend.
    Jacinto FV; Esteller M
    DNA Repair (Amst); 2007 Aug; 6(8):1155-60. PubMed ID: 17482895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA repair gene O6-methylguanine-DNA methyltransferase: promoter hypermethylation associated with decreased expression and G:C to A:T mutations of p53 in brain tumors.
    Yin D; Xie D; Hofmann WK; Zhang W; Asotra K; Wong R; Black KL; Koeffler HP
    Mol Carcinog; 2003 Jan; 36(1):23-31. PubMed ID: 12503076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
    Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
    Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.
    Esteller M; Risques RA; Toyota M; Capella G; Moreno V; Peinado MA; Baylin SB; Herman JG
    Cancer Res; 2001 Jun; 61(12):4689-92. PubMed ID: 11406538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
    Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
    Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.
    Wolf P; Hu YC; Doffek K; Sidransky D; Ahrendt SA
    Cancer Res; 2001 Nov; 61(22):8113-7. PubMed ID: 11719438
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.